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EFFECTS OF 
CRYOPRESERVATION ON 
THE PROLIFERATION AND 
ANTICOAGULANT ACTIVITY 
OF HUMAN SAPHENOUS 
VEIN ENDOTHELIAL CELLS 
Human saphenous veins were cryopreserved in 4% human albumin and 
10% dimethyl sulfoxide. The effect of cryopreservation endothelial cells 
was studied in terms of the anticoagulant activity of thrombomodulin and 
in terms of cell proliferation. After storage for 2 weeks at - 150 ° C, 0.45 --. 
0.07 × 10 s endothelial cells/cm 2 were detected in cryopreserved veins and 
1.03 --. 0.04 x l0 s endothelial cells/cm 2 in fresh veins (p < 0.01). The 
thrombin-catalyzed activation of protein C decreased after cryopreserva- 
tion, indicating altered thromhomodulin activity in the endothelial cells. 
On a cell number basis, the release of soluble thrombomodulin was 
three times higher from the cryopreserved endothelium than from the 
fresh endothelium (p < 0.05). The amount of spontaneous release of 
von Willebrand factor from the endothelial surface was not significantly 
different between fresh and cryopreserved veins. Endothelial cells were 
cultured from fresh veins and from their cryopreserved counterparts. On 
plating of endothelial cells in primary culture, the number of adhered 
cells was 0.9 ± 0.09 × 103 cells/cm 2from fresh veins and 0.25 ± 0.03 × 
103 cells/cm 2 from cryopreserved veins (p < 0.01). The positive immu- 
nohistochemicai stain for von Willehrand factor indicated that the 
endothelial cell character was maintained after cryopreservation. The 
endothelial desquamation with loss of anticoagulant function and 
the slow proliferation of surviving cells in vitro suggest an impaired 
endothelial healing in vivo. The loss of anticoagulant activity compli- 
cates the problems of the exposure of thrombogenic subendothelial 
matrix to blood in implanted cryopreserved veins. (J THORAC CARDIO- 
VASC SURG 1995;110:998-1004) 
L. S. Bambang, DVM, J. P. Mazzucotelli, MD, M. Moczar, PhD, 
F. Beaujean, MD, a and D. Loisance, MD, Cr~teil, France 
C ryopreserved blood vessel allografts that re- tained their native extracellular matrix and cel- 
lular integrity with a decreased immunologic reac- 
tion on transplantation could be a material of choice 
to replace autografts in arterial revasculariza- 
tions. 1'2'3 The clinical failures of cryopreserved 
human venous homografts have been associated 
with decreased function of endothelial cells in the 
cryopreserved grafts)'  4, 5 The use of dimethyl sulf- 
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oxide (DMSO) as cryoprotectant improves cell sur- 
vival,3, 6 and the results of functional analysis of 
cryopreserved venous autografts avoiding immu- 
norejection in a canine model are promising. 7'8, 9 
The aim of our study was to determine the viability 
and anticoagulant function of endothelial cells in 
human saphenous veins in vitro after cryopreserva- 
tion and thawing. We evaluated particularly the 
thrombomodulin activity, because one mechanism 
of the regulation of the natural anticoagulant path- 
way involves thrombomodulin for protein C activa- 
tion. 1° To obtain information on the ability of the 
injured endothelium to recover after cryopreserva- 
tion, we investigated the behavior of endothelial 
cells cultured from cryopreserved veins and from 
fresh veins. We extended our studies also to cryo- 
preservation of endothelial cells cultured from fresh 
veins, to differentiate between the effect of the 
cryopreservant and the effect of cryopreservation f 
tissue rather than cells. 
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Materials and methods 
Endothelial cells were collected by mechanical scraping 
from internal saphenous veins from patients undergoing 
coronary bypass operations. Pooled human AB serum was 
obtained from Centre de Transfusion Sanguine (Les Ulis, 
France). M 199 and RPMI 1640 culture medium (Roswell 
Park Memorial Institute, Buffalo, N.Y.), antibiotics, and 
additives to cell cultures were purchased from Gibco 
(Cergy, France) and 2% gelatin solution for cell culture 
from Sigma Chemical Company (St. Louis, Mo.). Human 
thrombin was a gift from Biotransfusion (Roissy, France). 
Purified protein C, recombinant r-hirudin, chromogenic 
peptide substrate CBS 4246 and CBS 0041 for activated 
protein C, activated protein C, Asserachrom yon Wille- 
brand Factor ELISA Kit, and Asserachrom Thrombo- 
modulin ELISA Kit were obtained from Diagnostica 
Stago (Asni6res, France). Lyophilized human plasma pro- 
teins were obtained from Biotransfusion (Roissy, France). 
DMSO and May-Grfinwald-Giemsa reagent were ob- 
tained from Merck (Darmstadt, Germany). Optimal cut- 
ting temperature (O.C.T.) medium for frozen tissue sec- 
tions was acquired from Miles (Elkhart, Ind.) and Immu- 
Mount aqueous mounting medium from Shandon 
(Pittsburgh, Pa.). Rabbit immunoglobulins to human yon 
Willebrand factor (vWF) and sheep immunoglobulin were 
purchased from Dakopatts (Dako, Trappes, France). 
Sheep antibody to human thrombomodulin was a kind gift 
from Dr. M. C. Boffa (INSERM U 150, Paris, France). An 
Elite ABC Kit employing the detecting reagent Vec- 
tastain, an avidin-biotinylated horseradish peroxidase 
complex was acquired from Vector (Burlingame, Calif.). 
Sampling of veins. Forty veins obtained from patients 
undergoing coronary artery bypass operations were each 
divided into two segments of identical ength (approxi- 
mately 3 cm) in the operating room; they were immersed 
immediately into 25 ml of transport solution containing 
NaC1 (0.15 mol/L) and glucose (0.01 mol/L) and were 
transported in less than 10 minutes at room temperature 
into the laboratory. One segment from each vein was 
submitted to cryopreservation, and cell cultures were 
propagated from both the fresh samples and the cryopre- 
served counterparts after thawing, as described in the 
following sections. 
Cryopreservation of veins. The cryopreservation of 
veins was performed in Centre D6partemental de Trans- 
fusion Sanguine (CHU Henri Mondor, Cr6teil, France). 
The veins were removed from the transport solution and 
were soaked in 15 ml of a sterile solution of 4% human 
albumin (Biotransfusion, Lille, France) and 10% DMSO 
in water for 30 minutes at 4 ° C. The veins in this solution 
were transferred into plastic bags and were chilled to 
-80°C by decreasing the temperature I °C per minute. 
The frozen veins were stored in vapors of liquid nitrogen 
at -150°C for 2 weeks. The cryopreserved veins were 
allowed to thaw for 2 to 3 minutes in a water bath at 37 ° C. 
Then the veins were removed from the preserving solution 
and were immersed at room temperature in NaC1 (0.15 
mol/L) and glucose (0.01 mol/L) (25 ml per vein) to 
eliminate DMSO. 
The endothelial cells from cryopreserved veins were 
cultured, and their biologic activity was studied in terms of 
their response to stimulation by thrombin, as described in 
the following sections. 
Crynpreservatinn of cultured endothelial cells. Con- 
fluent cultures of second-passage c ils propagated from 
fresh veins were trypsinized, and 7.5 × 105 cells were 
suspended in 1 ml aqueous 4% human albumin and 10% 
DMSO. The suspension was refrigerated, frozen, and 
stored in liquid nitrogen vapors along with the cryopre- 
served veins. 
Histology 
Veins. Cryopreserved vein segments were fixed in 4% 
formalin in phosphate-buffered saline solution (PBS), 
embedded in paraffin, and stained routinely with hema- 
toxylin-eosin-saffron. Immunohistochemical detection of 
thrombomodulin was carried out with sheep immuno- 
globulins to human thrombomodulin on 5 tzm cyrocut 
sections embedded in O.C.T. medium. The sections on 
the microscope slides were incubated with 150/xl diluted 
(1:100) antibody at 4°C overnight. Biotinylated swine 
multilink secondary antibody complexed with avidin-bi- 
otin-horseradish peroxidase and 3-amino-9-ethyl-carba- 
zole were used for staining. 
Cells. The characteristic cobblestone shape of endothe- 
lial cells in culture was observed under a phase-contrast 
microscope (Olympus CK2, Olympus Optical Co., Ltd., 
Tokyo, Japan) and under brightfield light illumination in a 
binocular microsCope (Olympus SZ 40 PT) after fixation 
of the cells with 1% formalin in PBS and staining with 
May-Grtinwald-Giemsa reagent. The stained cells were 
counted under the light microscope. Immunohistochemi- 
cal detection of factor VIII-related antigen (vWF) was 
carried out after fixation of cultured cells with 1% forma- 
lin in PBS. An avidin-biotinylated horseradish peroxidase 
complex was the detecting reagent. 
Cell cultures. Endothelial cells collected from fresh 
and cryopreserved human saphenous veins by scraping 
were cultured routinely as described previously. 11 In brief, 
cells were cultured in 2 ml RPMI 1640/M 199 culture 
medium containing L-glutamate, 2 mmol/L, penicillin, 100 
IU/ml, streptomycin, 100 txg/ml, fungizone, 2.5/zg/ml, and 
30% pooled human AB serum and then plated onto 3.5 
cm diameter polystyrene culture dishes precoated with 0.5 
ml human plasma proteins (3 mg/ml). After 24 hours, the 
nonadhered cells were aspirated off with the culture 
medium. Cells were cultured in a humidified atmosphere 
containing 95% air and 5% carbon dioxide, and the 
medium of proliferating cells was changed every 2 days. 
The population doubling time was calculated from the cell 
numbers, which were obtained by counting the cells under 
phase-contrast microscopy every 2 days after seeding. The 
medium in confluent cultures was changed aily. Conflu- 
ent cells were detached with 0.05% trypsin and 0.02% 
ethylenediaminetetraacetic acid and seeded with a 1:3 
split ratio for subcultivation. In assays for cell adherence, 
2 x 104 cells were seeded onto polystyrene culture dishes 
coated with fibronectin (10 txg/cm2). 
Biochemical assays 
The thrombomodulin activity of endothelial cells in veins. 
The technique described for cultured endothelial cells 12 
was applied to the endothelial layers of both fresh and 
cryopreserved veins. The veins were opened longitudi- 
nally, washed with 20 ml PBS, and inserted between two 
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Fig. 1. Culture chamber to test endothelial function in 
veins. 
polystyrene plates (6 x 3 x 2 cm), the upper plate bearing 
two perforated wells. In the upper plate in each well, 0.55 
cm 2 endothelial surface could be incubated with 200/xl of 
medium. The veins were fixed with Inox pins (Broadwest 
Corp., New York, N.Y.) (Fig. 1). The cells in one of the 
wells were used for the blank assay. To remove blood 
proteins, the endothelial surfaces were incubated in the 
wells with 200 t~l RPMI 1640/M 199 culture medium 
containing human serum albumin (10 mg/ml) for 20 
minutes at 37 ° C and then rinsed three times with 200 ~1 
of the same medium. The thrombomodulin activity was 
evaluated by activation of cells with 20/xl human thrombin 
(0.25 IU/ml) in the presence of 30 /xl protein C (65 
nmol/L) in 150 txl RPMI 1640/M 199 culture medium for 
90 minutes at 37 ° C. Then the thrombin was blocked by 20 
/xl liirudin (1.25 antithrombin U/ml). The supernatant was 
centrifuged, and the amidolytic activity of the generated 
protein C was measured in 150 /~1 aliquots on 40 /xl 
chromogenic peptide substrate (CBS 4146 or CBS 0041; 
0.05 mmol/L final concentration) by reading optical den- 
sities at 405 nm in a Dynatech MR 500 microplate reader 
(Dynatech Laboratories, Inc., Chantilly, Va.). The amido- 
lytic activity of the reference cell layer, not incubated with 
thrombin, was used as a blank to correct optical density 
values. At the end of the reaction, the cells were incubated 
with crystal violet, and the released nuclei were counted. 
Release of soluble thrombomodulin a d vWF. The veins 
were inserted into the polystyrene plates (see Fig. 1) as 
described for the determination of thrombomodulin ac- 
tivity. The amount of thrombomodulin released sponta- 
neously into the culture medium from the endothelial 
surface during 48 hours was determined by enzyme-linked 
immunosorbent-assay (Asserachrom Thrombomodulin 
ELISA Kit). The secretion of vWF was measured after 
incubation of cells for 6 hours in 200/xl RPMI 1640/M199 
culture medium in the absence and in the presence of a 1 
U/ml concentration f thrombin. The Asserachrom yon 
Willebrand Factor ELISA Kit was used for the determi- 
nation. 
Statistical methods. Results are expressed as means ___ 
standard error of the mean and compared by the Student's 
A 
Fig. 2. Immunohistochemical detection of thrombo- 
modulin in fresh vein (A) and in cryopreserved human 
saphenous vein (B). (Original magnification x 160.) 
Staining by the reaction of peroxydase-labeled antibody 
with 3-amino-9-ethyl carbazole. Counterstaining with 
Harris hematoxylin. 
t test. The p value was calculated by the nonparametric 
Wilcoxon test. 
Results 
Histologic characteristics and function of endo- 
thelial cells in fresh and cryopreserved veins 
Histologic characteristics. The reaction with anti- 
thrombomodul in antibody on the histologic sections 
revealed a continuous endothelial layer in the fresh 
veins (Fig. 2, A)  and partial endothelial desquama- 
tion in cryopreserved veins (Fig. 2, B). The immu- 
nohistochemical staining of  thrombomodul in  dif- 
fused into the upper medial layers of  cryopreserved 
veins. After release and staining of the cell nuclei 
with crystal violet, 1.03 + 0.04 x 105 and 0.45 -+ 
0.07 x 105 cells were counted per square centimeter 
of endothelial surface of fresh veins and cryopre- 
served veins, respectively (p < 0.01). 
pMllO 4 cells 
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Fig. 3. Thrombomodulin activity of endothelial cells 
from fresh and from matched cryopreserved veins, as 
indicated by the amount of activated protein C generated 
within 90 minutes after stimulation of endothelial cells by 
thrombin (p < 0.067'by the Wilcoxon test). F (triangles), 
Fresh veins; C (circles), cryopreserved veins. 
Thrombomodulin activity. The endothelial cells in 
the veins in situ were assayed for their ability to 
activate protein C in the presence of thrombin. On 
the basis of cell number, the thrombomodulin activ- 
ity was decreased in cryopreserved veins compared 
with the fresh endothelium (Fig. 3). The amounts of 
protein C activated in response to thrombin were 
10.52 +-- 2.52 and 1.01 +-- 0.36 pmol (p < 0.01) per 
square centimeter of endothelial surface in fresh 
veins and cryopreserved veins, respectively. These 
data indicated that the endothelial dysfunction ac- 
centuated the effect of endothelial desquamation 
the loss of anticoagulant function. The cryopre- 
served endothelium spontaneously released ahigher 
amount of soluble thrombomodulin to the me- 
dium than the fresh cells did (Fig. 4). The assay of 
protein C activation indicated that this soluble form 
was devoid of anticoagulant activity. 
Secretion ofvWF. The fresh endothelium and the 
cryopreserved endothelium secreted 0.36 +_ 0.06 
and 0.68 _+ 0.34 U vWF per 104 ceils, respectively, 
over a period of 6 hours (not significant). Thrombin 
increased the secretion of vWF by 30% in the fresh 
cells, but the secretion of vWF was only about 2% 
higher than basal values in the cryopreserved ndo- 
thelium. 
Culture of endothelial cells from fresh veins and 
cryopreserved veins. Endothelial cell suspensions 
from veins were assayed for adherence and prolif- 
eration. The number of the adhered cells was 0.9 ___ 
ngllO 4 cells 
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Fig. 4. Spontaneous release of soluble thrombomodulin 
from the endothelial layer of fresh veins (open column) 
and cryopreserved veins (black column). Results are 
means +- standard error of the mean from five indepen- 
dent determinations (p < 0.05). 
0.09 × 103 cells/cm 2 from the fresh veins and 0.2 + 
0.03 × 103 cells/cm 2 from their cryopreserved coun- 
terparts (p < 0.01). The cells seeded from fresh 
veins were grown to confluency in about 2 weeks, 
whereas the proliferation of cryopreserved cells was 
retarded. At the sixteenth day of culture, their cell 
density was approximately one tenth of that of the 
fresh cells (Fig. 5). After subcultivation i the first 
passage, fresh cells and cryopreserved cells (n = 11) 
proliferated with an essentially identical population 
doubling time: 39.4 _ 2 and 40.0 _+ 3 hours, 
respectively. Both fresh and cryopreserved cells 
exhibited cobblestone-like structure and positive 
immunohistochemical staining for vWF. 
The cryopreservation process was applied also to 
cell suspensions from confluent cultures propagated 
from fresh veins. The proliferation and the throm- 
bomodulin activity of the cryopreserved cells after 
thawing was compared with that of fresh cells of the 
same origin and passage. The number of adhered 
cells at 2 hours after seeding shows that the plating 
efficiency of fresh cells was significantly higher than 
that of cryopreserved cells. Nevertheless, the ad- 
hered cryopreserved cells proliferated at the same 
rate as fresh cells (Fig. 6), in contrast to cells 
cultured from cryopreserved veins (Fig. 5). At day 1 
in culture, the thrombomodulin activity was lower by 
a factor of about 3 in cryopreserved cells compared 
with fresh cells. At the third day after seeding in 
dense cultures, the thrombomodulin activity and the 
secretion of vWF of cryopreserved cells equaled that 
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Fig. 5. Proliferation of endothelial cells harvested from 
fresh and from cryopreserved human saphenous veins. 
Results are means from eleven independent determina- 
tions _+ standard error of the mean. Differences between 
fresh and cryopreserved cells are significant (p < 0.01) at 
each time point. Triangles, cells from fresh veins; circles, 
cells from cryopreserved veins. 
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Fig. 6. Proliferation of flesh cells (triangles) and cryopre- 
served cells (squares) cultured from fresh human saphe- 
nous veins. Results are means from six independent 
determinations _+ standard error of the mean, Differences 
between fresh and cryopreserved cells are significant (p < 
0.01) at each time point. 
of flesh cells and were similar to those measured in 
flesh veins. 
Discussion 
Cryopreservation of human saphenous veins in 
4% albumin and 10% DMSO resulted in loss of 
about 50% of the endothelial cells. The decreased 
thrombomodulin activity and the increased re- 
lease of soluble thrombomodulin reflect an im- 
paired anticoagulant function of the remaining 
cells. The endothelial cells harvested after thaw- 
ing exhibited poor adherence and retarded prolif- 
eration in primary culture compared with cells 
from fresh veins. 
In previous works, 3" 8, 13 the endothelium-depen- 
dent contractile responses in cryopreserved veins 
have been thoroughly investigated. The results of 
functional analyses of fibrinolytic activity 1and pros- 
tacyclin secretion 5' 7 suggest hat the modifications 
in the biologic activity of cryopreserved veins are not 
limited to the changes in vascular tone. Endothelial 
cells participate actively in preventing blood coagu- 
lation in vivo. Therefore it is of interest o obtain 
information on the anticoagulant function of endo- 
theliuml0, 14, 15 in cryopreserved veins. 
The thrombomodulin expressed on the endo- 
thelial cell surface plays a key role in the regulation 
of the anticoagulant properties of the endothe- 
lium.14, 16 Thrombomodulin s a receptor for throm- 
bin, and the rate of protein C activation increases 
about 1000-fold when thrombin is complexed by this 
receptor. 1° The activated protein C can cleave the 
coagulation cofactors Va and VIIIa, preventing 
thrombin formationJ ° The alteration of the macro- 
molecular specificity of thrombin by its binding to 
thrombomodulin explains the fact that the com- 
plexed thrombin loses its procoagulant properties: it
no longer catalyzes the formation of fibrin from 
fibrinogen, 17 and its ability to activate platelets is 
blocked. 18 
To evaluate the effect of cryopreservation the 
endothelial anticoagulant function, we compared 
thrombomodulin activity of fresh veins with that of 
their cryopreserved counterparts. We detected a 
lower thrombomodulin activity (see Fig. 3) and a 
higher release of soluble thrombomodulin (see Fig. 
4) in cryopreserved veins than in the fresh samples. 
Decreases in thrombomodulin activity on the sur- 
face of human umbilical endothelial cells and of 
cells from the A549 lung cancer cell line, 19 in 
culture, 2° have been correlated to the endocytosis of 
the thrombin-thrombomodulin complex and not to a 
release of thrombomodulin. Increased levels of sol- 
uble thrombomodulin i  the human serum have 
been reported as a marker of endothelial dam- 
age 2°-22 in ischemic heart disease 23 and in athero- 
matous arterial disease. 24 Thrombomodulin is a 
transmembrane protein, 14' 16 and its shedding into 
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the medium could be originated by a proteolytic 
activity provoked by cryopreservation. 
Unlike protein C activation, 1°the thrombin-me- 
diated release of vWF does not appear to involve 
high-affinity binding sites on endothelial cells. 25 The 
vWF secreted by the endothelial cells 26 promotes 
platelet adhesion to the damaged vessel wall, 27 and 
it can be a marker of vascular disorders in plasma. 2a 
The great variations in vWF tend to show that the 
procoagulant function of cryopreserved cells can be 
altered at least up to 6 hours after thawing. 
To evaluate the potential of endothelial recovery 
after cryopreservation, we cultured endothelial cells 
from fresh veins and from their cryopreserved coun- 
terparts. Cryopreserved cells proliferated more 
slowly in primary culture than did cells from fresh 
veins. One possible explanation is alteration of cell 
membrane proteins by mechanical breakdown or by 
proteolysis during the freezing and thawing steps. 
The apparent return to the normal proliferation 
rate in cryopreserved cells after first passage could 
reflect either recovery or selection of an endothelial 
population 2s by cryopreservation and subculti- 
vation. When cultured cells from fresh veins 
were cryopreserved in the form of isolated cells, 
the cells restored their proliferation rate with 3 
days (Fig. 6). Therefore, cryopreserved cell sus- 
pensions recover apparently faster than cell cul- 
tures propagated from cryopreserved veins. This 
difference points to the technical difficulties of 
cryopreservation f cells with their extracellular 
matrix in a blood vessel wall. The DMSO cryopro- 
tectant appears to be more efficient on isolated 
cells than on the whole tissue. 
The slow proliferation rate of cells harvested from 
cryopreserved veins suggests an impaired endothe- 
lial healing in these veins in the clinical setting. The 
endothelial desquamation could be greater after an 
arterial implantation under pulsatile blood flow than 
after thawing in situ. The cumulative ffect of deen- 
dothelialization and decreased thrombomodulin ac- 
tivity of surviving cells could result in a persisting 
exposure of thrombogenic subendothelial matrix to 
blood. This interpretation of our results in vitro is 
supported by the poor patency and lack of reendo- 
thelialization in distal bypasses with cryopreserved 
human saphenous vein allografts, z9 
We thank Charles Wildevuur, MD, PhD, for helpful 
discussion and for reviewing the manuscript and Maryvonne 
Ginat for technical assistance. 
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